metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology Identification and study of differentially expressed miRNAs in aged NAFLD rats b...
Journal Information
Vol. 19. Issue 3.
Pages 302-312 (May - June 2020)
Share
Share
Download PDF
More article options
Visits
1958
Vol. 19. Issue 3.
Pages 302-312 (May - June 2020)
Original article
Open Access
Identification and study of differentially expressed miRNAs in aged NAFLD rats based on high-throughput sequencing
Visits
1958
Ying Zhanga,b, Danni Xianga, Xiaona Hua,b, Qingwei Ruanb, Lina Wangb, Zhijun Baoa,b,
Corresponding author
zhijunbao@fudan.edu.cn

Corresponding author at: Department of Gastroenterology, Shanghai Key Laboratory of Clinical Geriatric Medicine, Huadong Hospital, Fudan University, No. 221, Yan’an West Road, Shanghai 200040, China.
a Department of Gastroenterology, Huadong Hospital, Fudan University, Shanghai, China
b Shanghai Key Laboratory of Clinical Geriatric Medicine, Huadong Hospital, Fudan University, Shanghai, China
This item has received

Under a Creative Commons license
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (9)
Show moreShow less
Tables (5)
Table 1. Primer sequences.
Table 2. Comparison of serum markers for insulin resistance.
Table 3. Differently expressed miRs in the aged NAFLD group vs. in control group.
Table A.1. Upregulated miRs.
Table A.2. Downregulated miRs.
Show moreShow less
Abstract
Introduction and objectives

Hepatic microRNA (miR) expression profiles were explored in aged rats with NAFLD, in order to clarify the molecular mechanisms underlying the pathophysiological processes of aging-related NAFLD.

Patients or materials and methods

24 aged rats (18-month-old) and 24 young rats (2-month-old) were randomly divided into two subgroups according to diet, control group and NAFLD group. After 8 weeks of administering 45% high-fat diet or normal diet, total hepatic RNA was extracted from liver tissues of the aged rats. Differentially expressed microRNAs (DE-miRs) in aged NAFLD group were detected and screened out using high-throughput sequencing technology. The data were subjected to Gene Ontology functional enrichment and Kyoto Encyclopedia of Genes and Genomes pathway analyses using a bioinformatics approach. The sequencing results were further verified by RT-qPCR.

Results

Compared with the aged control liver tissues, 6 significantly upregulated miRs (miR-881-3p, miR-871-3p, miR-335, miR-223-3p, miR-155-5p, miR-146b-5p) and 4 significantly downregulated miRs (miR-182, miR-193-3p, miR-31a-5p and miR-96-5p) were identified in the aged NAFLD liver tissues. These DE-miRs were found to be involved in the regulation of cell signaling transduction and metabolism processes, probably affecting signaling pathways relevant to insulin secretion and some senile diseases. RT-qPCR results corroborated the sequencing results and demonstrated that 6 significantly upregulated miRs were not identified in the young group.

Conclusions

A total of 10 DE-miRs identified in the aged NAFLD rats were involved in some certain insulin secretion and age-related functional pathways, which may serve as novel candidate targets for the diagnosis and treatment of aging-associated NAFLD.

Keywords:
Aging
Non-alcoholic fatty liver disease
MicroRNA
High-throughput sequencing
Real-time PCR
Full Text
1Introduction

Non-alcoholic fatty liver disease (NAFLD) is one of the most common liver diseases in the world. The prevalence of NAFLD has generally increased over the past 20 years. At the same time, the incidence of NAFLD increased with age. Increasing evidence has revealed the pathogenetic features of NAFLD; however, the detailed mechanisms underlying the development of NAFLD in aged populations remain largely unknown.

MicroRNAs (miRs) are small RNA molecules typically 19–25 nucleotides (nt) in length, which have no protein-encoding capability. miRs participate in the regulation of a range of biological processes, including cell proliferation, differentiation, senescence and apoptosis, by binding to the 3′-untranslated region (3′-UTR) of the mRNAs of target genes, thereby leading to translational inhibition prior to mRNA degradation [1,2]. Recently, a set of miRs have been identified to play pivotal roles in metabolic diseases and the aging process via regulation of specific signaling pathways in many species including nematodes, Drosophila, mice and humans [3]. miRs have distinct expression profiles depending on the cell type and the organism's physiological/pathological status. For example, miR-33a/b, miR-122, miR-29, miR-126, miR-96 and miR-192 have been reported to be associated with insulin resistance in the liver [4–6]. miR-34a, miR-217, miR-449, miR-22, miR-199a, miR-132 and miR-486-5p have been identified to be involved in the aging process [7–9]. However, the studies above only detected changes in the expression of these miRs without analyzing their functional relevance to specific diseases. To the best of our knowledge, no published work has investigated expression patterns in hepatic miRs in aged-related NAFLD until now. This lack of data hinders further elucidation of the molecular mechanisms involved in insulin resistance in the liver of the aged population.

In the present study, hepatic microRNA expression profiles in aged rats with NAFLD were explored systemically using high-throughput sequencing technology, as well as the aged control rats. The identified differentially expressed microRNAs (DE-miRs) between the aged NAFLD rats and the aged control rats were analyzed for functional relevance using a bioinformatics approach, in order to clarify the molecular mechanisms underlying liver insulin resistance in the pathological processes of aging-related NAFLD.

2Materials and methods2.1Animals and experimental design

Specific pathogen-free Sprague-Dawley rats (24 male 18-month-old rats weighing 650–800g and 24 2-month-old rats weighing 200–220g) were provided by Changsha Tianqin Biological Technology Co., Ltd. (Hunan Province, China) (licence number: SCXK (Hunan) 2014-0011). After 1 week of adaptive feeding, the rats in each group were randomly divided into two subgroups according to diet (n=12 per group): (i) aged NAFLD group (18-month-old rats); (ii) aged control group (18-month-old rats); (iii) young NAFLD group (2-month-old rats); and (iv) young control group (2-month-old rats). NAFLD groups were administered a diet consisting of 45% high-fat respectively, which was composed of 54.8% normal diet, 18.9% lard, 1.3% bile the sterol, 0.3% bile salts, 11.2% sucrose, 8.7% casein, 1.8% premix and 3% maltodextrin (with the ratio of 18% crude protein, 45% fat and 37% carbohydrate). Rats of the control groups were fed a standard laboratory chow. All dietary components were provided from Pu Lu Teng Biological Technology Co., Ltd. (Shanghai, China). The rats were maintained in a controlled environment (25°C on a 12-h light/dark cycle) and had free access to water and laboratory fodder. None of the rats died during the feeding process. All animal protocols in this study were approved by the Animal Care and Use Committee of Laboratory Animal Center, School of Pharmacy, Fudan University (Shanghai, China).

2.2Sample collection and serological examination

After 8 weeks of receiving continuous high-fat diet [10] or normal diet, all the rats were anesthetized and sacrificed with an intraperitoneal injection of sodium pentobarbital (40mg/kg), followed by overnight fasting for 12h. Blood samples were immediately collected from the abdominal aorta, and the livers were removed via aseptic laparotomy. Serum was obtained by centrifugation at 3500rpm for 10min, then frozen and stored at −80°C prior to biochemical analysis. Fasting blood glucose (FBG) levels were measured using an automatic analyzer (Modular D2400, Roche Diagnostics). Fasting serum insulin (FINS) levels were assessed using a fully automated chemiluminescence analyzer (Maglumi-4000, Shenzhen, China). The insulin resistance index was measured using the homeostasis model assessment (HOMA-IR). The following formula was used: FINS level (mIU/l)×fasting glucose level (mmol/l)/22.5.

2.3Tissue preparation and histology

Liver tissues were cut into several small pieces for subsequent histological analysis. Some were fixed in 4% paraformaldehyde, sliced into 3-μm-thick sections, embedded in paraffin, and stained with hematoxylin and eosin (H&E) using the standard method. A single observer who was blinded to this experiment photographed and examined H&E staining using a light microscope (DS-Fi1, Nikon Corporation). Each sample was given an NAFLD activity score (NAS) [11,12]. This system numerically rates macrosteatosis (0–3), lobular inflammatory changes (0–3), and hepatocyte ballooning (0–2). A NAS <3 correlates with mild non-alcoholic fatty liver, a NAS of 3–4 correlates with moderate non-alcoholic fatty liver, and a NAS ≥5 correlates with NASH [11]. Some liver samples were embedded in optimum cutting temperature compound (OCT, Sakura Finetek, USA), sliced into 10-μm-thick sections and then stained with the diluted Oil Red O solution (Sangon Biotech Co., Ltd.). Formation of lipid droplets in liver tissues was observed under a light microscope (DS-Fi1, Nikon Corporation) and photographed. The remaining liver samples were frozen in liquid nitrogen rapidly and then stored at −80°C until further analysis.

2.4Hepatic RNA isolation and purification

Liver tissues randomly pooled from 3 rats of the aged NAFLD group were compared with tissues pooled from 3 aged control rats. Total hepatic RNA was extracted using the mirVana™ miRNA Isolation kit (Ambion, Thermo Fisher Scientific, Inc.) according to the manufacturer's instructions. The purity of isolated RNA was established by electrophoresis using an Agilent 2100 Bioanalyzer (Agilent Technologies, Inc.) according to the procedures described by Chen et al. [13].

2.5Gene library construction and sequencing

Sequencing was performed by Shanghai Bohao Biotechnology Co. Briefly, 1.0μg of total RNA was subjected to 3′ adapter linkage and 5′ adapter linkage using T4 RNA ligation (New England Biolabs, Inc.) according to the manufacturer's instructions. The ligation products were subsequently reverse-transcribed into cDNA using SuperScript II Reverse Transcriptase (Invitrogen, Thermo Fisher Scientific, Inc.) and PCR amplified using an Illumina sequencing kit (Illumina, Inc.) to generate a cDNA library according to the previous studies [13]. The following program was used for amplification: 98°C for 30s; 98°C for 10s, 60°C for 30s, and 72°C for 15s, followed by 11 cycles at 72°C for 10min. The cDNA library was quantitatively analyzed on a Qubit® 2.0 Fluorometer (Invitrogen, Thermo Fisher Scientific, Inc.), and its size was measured using an Agilent Bioanalyzer (Agilent, Thermo Fisher Scientific, Inc.). Cluster generation and single-read sequencing were conducted on an Illumina HiSeq instrument according to the manufacturer's instructions (Illumina, Inc.).

2.6Data analysis

Sequence alignments and comparisons were conducted using the miRBase database 19.0, to identify and classify the number and distribution of known miRs, in addition to various forms of small RNA molecules. No base pair mismatches were allowed. EdgeR software (version 3.24) was used for comparing the abundance of miRs in the liver tissues from the aged NAFLD group with those from the aged control group. Data were presented as transcripts per million (TPM) and were calculated using following formula: TPM=(miR read number/total read number)×106[14]. Fold change in expression was calculated as TPMNAFLD rats/TPMcontrol rats[2,15]. DE-miRs were defined as the fold change in expression of >2 or <0.5 between the two groups (aged NAFLD group and aged control group) with a false discovery rate (FDR) of <0.05 [2,15].

2.7Bioinformatics analysis for DE-miRs

The potential target genes of DE-miRs were predicted using miRanda (www.microrna.org), followed by pathway enrichment analysis using Gene Ontology (GO) (www.geneontology.org) and Kyoto Encyclopedia of Genes and Genomes (KEGG) (www.kegg.jp) databases according to previous studies [16–18]. P values were calculated from the hypergeometric distribution. P<0.05 was considered statistically significant [19].

2.8Reverse transcription-quantitative PCR (RT-qPCR)

To confirm the expression of DE-miRs identified by the deep sequencing, further analysis was performed using RT-qPCR with the same total RNA samples of the liver tissues used for the construction of the sequencing library. Then the DE-miRs were also confirmed in liver samples in all of 24 aged rats and 24 young rats using RT-qPCR. PCR primers were synthesized by Shanghai Shengong Biotechnology Company. Total RNAs were isolated from each hepatic sample using an mirVana™ miRNA Isolation kit (Ambion, Thermo Fisher Scientific, Inc.) and reverse transcribed into cDNA using the miScript II Reverse Transcriptase Mix (Qiagen, Inc.) according to the manufacturer's protocol. The RT reaction conditions were as follows: 37°C for 60min, 95°C for 5min. The relative gene expression was determined using a 7900 HT Sequence Detection System (ABI, USA). The parameters of the PCR protocol were as follows: 95°C for 2min, followed by 40 cycles at 94°C for 15s, and then 60°C for 1min. All reactions were run in triplicate. miR expression was calculated using the 2−ΔΔCq method [2] and normalized to rno-U6 expression. Primer sequences are presented in Table 1.

Table 1.

Primer sequences.

Primer  5′–3′ 
rno-miR-96-5p  TTTGGCACTAGCACATTTTTG 
rno-miR-881-3p  GGAACTGTGGCATTTCTGAATAG 
rno-miR-871-3p  TGACTGGCAACATACTGGATAAA 
rno-miR-223-3p  TGTCAGTTTGTCAAATACCCCAA 
rno-miR-193a-3p  CTGGCCTACAAAGTCCCAGT 
rno-miR-182  TTGGCAATGGTAGAACTCACAC 
rno-miR-155-5p  AATGCTGATTGTGATAGGGGT 
rno-miR-146b-5p  TGAGAACTGAATTCCATAGGCTGT 
rno-miR-31a-5p  AGGCAAGATGCTGGCATAG 
rno-miR-335  TCAAGAGCAATAACGAAAAATGTAA 
rno-U6  TTCGTGAAGCGTTCCATATTTT 
2.9Statistical analysis

Analyses were performed using SPSS software (version 22.0; SPSS, Inc., Chicago, IL, USA). Data were expressed as the mean±standard deviation for at least three independent experiments for each group. Multiple comparisons between the aged and the young groups were carried out by one-way analysis of variance (ANOVA) test with post hoc contrasts by least significance difference (LSD) test. P<0.05 was considered statistically significant.

3Results3.1Serum markers for insulin resistance

Table 2 shows serum insulin resistance data. The HOMA-IR value was distinctively higher in the NAFLD group than the control group (4.06±0.99 vs. 1.11±0.40, P=0.001). When compared with the young NAFLD group, serum insulin and HOMA-IR levels were significantly higher in the aged NAFLD group (8.24±2.97 vs. 4.15±1.07, P=0.049; 4.06±0.99 vs. 1.97±0.53, P=0.001). Among the four groups, HOMA-IR level of the aged NAFLD group was significantly increased (4.06±0.99 vs. 1.11±0.40 vs. 1.97±0.53 vs. 0.87±0.31, P=0.001).

Table 2.

Comparison of serum markers for insulin resistance.

  FBG (mmol/l)  FINS (mmol/l)  HOMA-IR 
Aged NAFLD group  11.77±3.08*,&  8.24±2.97*,&  4.06±0.99*,& 
Aged control group  8.45±1.33  2.95±0.73  1.11±0.40 
Young NAFLD group  10.75±1.61*  4.15±1.07*  1.97±0.53* 
Young control group  7.88±0.74  2.43±0.67  0.87±0.31 
F  5.637  15.284  33.871 
P value  0.005#  0.001#  0.001# 

All data were expressed as the mean±standard deviation for at least three independent experiments for each group, n=12. FBG, fasting blood glucose; FINS, fasting insulin; HOMA, homeostasis model assessment.

*

P<0.05 vs. the aged control group.

&

P<0.05 vs. the young NAFLD group.

#

P<0.05 among four groups.

3.2Histopathological examination

Under a light microscope, the liver tissues from NAFLD groups had damaged hepatic lobes with narrow or even absent sinus hepaticus, with fat vacuoles occupied the cytoplasm. All of which met the histological features of NAFLD [11]. Disarranged and diffuse enlargement of hepatocytes was observed in the NAFLD group, particularly in the aged NAFLD group, resulting in the cell nuclei being compressed to one side (Fig. 1). Aged NAFLD group exhibited predominantly macrosteatosis, with a little ballooning injury of the hepatocytes. NAFLD activity score (NAS) for the aged NAFLD group was 5.00±0.74, which was higher than that for the young NAFLD group (1.92±0.99, P<0.001) and the aged control group (0.75±0.45, P<0.001) (Fig. 2). NAFLD severity was more obvious in aged NAFLD group. Results of the Oil Red O assay further showed that more lipid droplets were deposited in NAFLD groups, particularly in the aged NAFLD group (Fig. 3).

Fig. 1.

H&E staining of liver tissues (magnification, 200×). Compared with young groups, hepatic cells of the aged groups were significantly larger. Hepatocytes of the NAFLD groups were disarranged, diffuse and enlarged. Fat vacuoles occupied the cytoplasm, compressed cell nuclei to one side, particularly in the aged NAFLD group. Percent macrosteatosis: H&E staining revealed predominantly macrosteatosis in 90% of hepatic cells in aged NAFLD group, which is higher than in young NAFLD group (45%) and aged control group (6%). No macrosteatosis was observed in young control group (0%). H&E, hematoxylin and eosin; NAFLD, non-alcoholic fatty liver disease.

(1.12MB).
Fig. 2.

NAFLD activity scores in the liver tissues. *P<0.01 compared with the young control group, **P<0.001 compared with the young NAFLD group, ***P<0.001 compared with the aged control group. NAS, NAFLD activity score.

(0.09MB).
Fig. 3.

Oil-red-O staining of liver tissues (magnification, 100×). Adipocytes are red and the nucleus is blue. More accumulation of lipid droplets was observed in NAFLD groups, which caused the pushing of the nucleus toward one side, particularly in the aged NAFLD group. NAFLD, non-alcoholic fatty liver disease.

(1.12MB).
3.3Quality of hepatic RNA and construction of the miR library

The RNA integrity number of all RNA samples was ≥7.0 and the 28S:18S ratio was ≥0.7. Results of electrophoresis confirmed the high purity of RNAs. The distribution of valid sequences in the two experimental groups had apparent similarities: The mature miRs ranged principally from 21 to 24 nt in length (mostly 22 nt) (Fig. A.1), indicating that the samples contained a concentrated distribution of RNA fragments, enabling subsequent successful bioinformatics analysis.

3.4High-throughput sequencing and identification of DE-miRs

Hepatic miR expression profiles were analyzed using edgeR software. After normalization of the TPM value, it was revealed that compared with aged control hepatic tissues, 116 miRs (Table A.1) were upregulated in the aged NAFLD hepatic tissues, of which 6 (miR-881-3p, miR-871-3p, miR-335, miR-223-3p, miR-155-5p, miR-146b-5p) were significantly upregulated. In addition, 116 miRs were downregulated (Table A.2), of which 4 (miR-96-5p, miR-193-3p, miR-182, miR-31a-5p) were significantly downregulated (Table 3).

Table 3.

Differently expressed miRs in the aged NAFLD group vs. in control group.

Genes  TPMFold change  P-value  FDR  Up/down regulation 
  HFD  Control         
miR-96-5p  27.121  55.997  0.484  0.003  0.028  Down 
miR-881-3p  0.781  0.272  2.875  7.10×10−7  9.34×10−6  Up 
miR-871-3p  0.580  0.146  3.978  1.05×10−12  2.09×10−11  Up 
miR-335  239.911  115.771  2.072  3.84×10−8  5.42×10−7  Up 
miR-223-3p  207.325  91.419  2.268  7.74×10−12  1.36×10−10  Up 
miR-193a-3p  40.716  83.822  0.486  0.001  0.002  Down 
miR-31a-5p  925.422  2141.458  0.432  3.39×10−12  6.14×10−11  Down 
miR-182  2168.670  4711.702  0.460  1.60×10−205  1.86×10−203  Down 
miR-155-5p  103.060  21.700  4.749  2.89×10−14  6.68×10−13  Up 
miR-146b-5p  2041.111  541.795  3.767  9.13×10−208  1.32×10−205  Up 

TPM, transcripts per million; TPM=(miR read number/total read number)×106. Fold change: The ratio of read counts in HFD group to that in control group, fold change=TPMHFD/TPMControl. FDR, false discovery rate. After normalization, obtained average values for each miR spot were used for statistics. miR with expression fold change >2 or <0.5, and with FDR <0.05 was considered statistically significant.

3.5Bioinformatics analysis of DE-miRs

GO functional enrichment analysis indicated that the DE-miRs were associated with four cell components, including the ribosome, cytosolic ribosome, ribosomal subunit, and cytosolic large ribosomal subunit. Further analysis demonstrated that the DE-miRs were associated with 11 molecular functions, including G-protein coupled receptor activity, signaling receptor activity, enzyme binding and ATP binding, and had involvement in the regulation of 25 biological processes, such as the G-protein coupled receptor signaling pathway, protein modification process, phosphorus metabolic process, intracellular signal transduction, developmental process and phosphorylation (P<0.01) (Fig. 4).

Fig. 4.

GO pathway analysis of the differentially expressed miRs in the aged rats. Enrichment score is equal to −log10(P_value). The higher the enrichment score is, the more specific the corresponding function is. X-coordinate represents the negative logarithm of P(−Lg; P_value). Y-coordinate denotes the name of the path. GO, Gene Ontology; miRs, microRNAs.

(0.37MB).

KEGG pathway enrichment analysis provided evidence that the DE-miRs were significantly enriched in MAPK, cAMP, pathways relevant to insulin secretion, glycerophospholipid metabolism, and certain age-related diseases including cancer, type-II diabetes, long-term depression and Parkinson's disease (P<0.05) (Fig. 5).

Fig. 5.

KEGG pathway analysis of the differentially expressed miRs in the aged rats. Enrichment score is equal to −log10(P_value). The higher the enrichment score is, the more specific the corresponding signaling pathway is. X-coordinate represents the negative logarithm of P(−Lg; P_value). Y-coordinate denotes the name of the path. KEGG, Kyoto Encyclopedia of Genes and Genomes; miRs, microRNAs.

(0.46MB).
3.6Verification of DE-miRs by RT-qPCR

RT-qPCR was conducted to verify the expression status of the DE-miRs in the aged groups. The results demonstrated that 6 upregulated miRs (miR-155-5p, miR-223-3p, miR-335, miR-871-3p, miR-881-3p and miR-146b-5p) and 4 downregulated miRs (miR-182, miR-193-3p, miR-31a-5p and miR-96-5p) identified through high-throughput sequencing displayed a similar trend of expression when evaluated using RT-qPCR (Fig. 6), indicating a high consistency in the aged groups between these two techniques. However, no such upregulation trends regarding the 6 upregulated miRs (miR-155-5p, miR-223-3p, miR-335, miR-871-3p, miR-881-3p and miR-146b-5p) were found in the young NAFLD group (Fig. 7). Of note, miR-223-3p demonstrated a higher upregulated expression level in the aged NAFLD group (fold change=2.268, P=7.74×10−12) by both high-throughput sequencing and RT-qPCR; however, which was not presented in the young NAFLD group (Fig. 7). While 4 downregulated miRs (miR-182, miR-193-3p, miR-31a-5p and miR-96-5p) in the aged NAFLD group were also indicated to be significantly downregulated in the young NAFLD group (Fig. 8).

Fig. 6.

Verification of differentially expressed miRs in the aged rats by RT-qPCR analysis. Y-coordinate represents fold change of miR expression levels in liver tissues of aged NAFLD group vs. aged control group, that is, the ratio of miR expression levels in aged NAFLD group to that in aged control group. miR-155-5p, miR-223-3p, miR-335, miR-871-3p, miR-881-3p and miR-146b-5p were significantly increased, whereas miR-182, miR-193-3p, miR-31a-5p and miR-96-5p were significantly decreased in aged NAFLD rats compared with control rats. miRs, microRNAs; Seq, high-throughput sequencing; qPCR, reverse transcription-quantitative polymerase chain reaction. In high-throughput sequencing analysis, differentially expressed miRs were defined as the fold change in expression of >2 or <0.5 between the two groups (aged NAFLD group and aged control group) with a false discovery rate (FDR) of <0.05.

(0.17MB).
Fig. 7.

Upregulated miRs in the aged and young groups were assessed using RT-qPCR analysis. Y-coordinate represents fold change of miR expression levels in liver tissues of NAFLD group vs. the control group. The upregulation trends of the 6 identified upregulated miRs (miR-155-5p, miR-223-3p, miR-335, miR-871-3p, miR-881-3p and miR-146b-5p) were not found in the young group. miRs, microRNAs; Seq, high-throughput sequencing; qPCR, reverse transcription-quantitative polymerase chain reaction.

(0.16MB).
Fig. 8.

Downregulated miRs in the aged and young groups were assessed using RT-qPCR. Y-coordinate represents fold change of miR expression levels in liver tissues of NAFLD group vs. the control group. The 4 downregulated miRs identified through high-throughput sequencing, that is, miR-182, miR-193-3p, miR-31a-5p and miR-96-5p, were also downregulated in the young NAFLD group which were assessed by RT-qPCR. miRs, microRNAs; Seq, high-throughput sequencing; qPCR, reverse transcription-quantitative polymerase chain reaction.

(0.12MB).
4Discussion

Hepatic insulin resistance is thought to be a core component of NAFLD [20]. HOMA-IR is a generally accepted method for quantifying insulin resistance in epidemiological studies. In the present study, serum insulin and HOMA-IR levels were significantly higher in the aged NAFLD group, which proved that insulin resistance occurred in aged NAFLD rats induced by high fat diet. Because of the unique process of natural aging and life habits conform to the human NAFLD evolution process [21], SD rats have been widely used in the fields of gerontology and geriatrics.

As we all know, aging and insulin resistance are complex biological processes regulated by multiple signaling pathways, and dysregulation of these pathways may lead to the initiation of disease or its progression. Currently, increasing evidence has revealed the etiological and epidemiological features of NAFLD, contributing to great progress in the diagnosis and prevention of NAFLD; however the detailed molecular mechanisms underlying the development of NAFLD in aged populations remain unclear. It has been reported that miRs functioned as crucial posttranscriptional regulators in liver metabolism [22,23]. Abnormally expressed miRs can bind to the 3′-UTR region of certain age-related genes, thereby altering their expression and affecting the aging process [7].

In the present study, a total of 10 differentially expressed miRs (6 upregulated and 4 downregulated) were identified through high-throughput sequencing technology in the aged rats with NAFLD, which confirmed by RT-qPCR analysis. Previous studies have reported that the most abundant miR in fatty liver was miR-122 which participated in the modulation of cholesterol and fatty acid metabolism [24,25]. Underexpression of miR-122 potentially contributes to altered lipid metabolism implicated in the pathogenesis of NASH [26]. Other highly-expressed miRs in fatty liver included miR-34a [27,28], miR-146a and miR-200b [29–31], which may affect the development of NAFLD by regulating the inflammatory response in lipopolysaccharide-stimulated Kupffer cells. However, expression patterns of the above mentioned miRs were not reflected in the present study. Furthermore, the 6 identified upregulated miRs (miR-881-3p, miR-871-3p, miR-335, miR-223-3p, miR-155-5p and miR-146b-5p) in the aged NAFLD group were not significantly upregulated in hepatic tissues of the young NAFLD group, further confirming that these identified DE-miRs were actually age related. A possible explanation for this discrepancy is that aging rats were used as subjects in the present study, and the impact of aging itself was excluded on the differential expression of miRs. Notably, NAFLD-associated miRs involved in regulating insulin resistance in aging organisms are different from that of young individuals. It remains unclear how these DE-miRs may affect lipid homeostasis of NAFLD in senescent organisms, and how they induce or aggravate the occurrence of hepatic insulin resistance of aged NAFLD. Some specific studies may be made to elicit how these DE-miRs effect on the pathogenesis of fatty liver and steatohepatitis in the elderly from a functional perspective.

It is estimated that miRs regulate 30–60% of protein-encoding genes, through which they exert an important influence on the pathological processes of many diseases [32]. Therefore, systemic prediction and identification of target genes regulated by a set of miRs during a pathological process, rather than analyzing a single miR-target interaction can provide a more accurate understanding of miR-based regulatory mechanisms in a particular disease.

In the present study, the 10 identified DE-miRs expressed in the aged NAFLD were found to be involved functionally in many biological processes, including intracellular signaling transduction, regulation of metabolism, the developmental process and phosphorylation. Furthermore, the results of KEGG enrichment analysis demonstrated that these DE-miRs were mainly enriched in mitogen-activated protein kinase and cAMP signaling, which are pathways closely associated with insulin secretion and glycerophospholipid metabolism. Moreover, the DE-miRs were also found to be associated with signaling pathways related to some senile diseases, including cancer, type II diabetes, long-term depression and Parkinson's disease, suggesting that they may also participate in the regulation of a number of other age-related biological processes, such as tumor formation or diseases of the nervous system.

In order to evaluate the specific effects of these DE-miRs on regulating lipid intake of the aged hepatic cells further and elucidate how they involve in this procedure, we intend to search for and verify the target genes or target proteins downstream of each miR according to GO and KEGG enrichment analysis results in the future experiments. As indicated in the previous literatures [33,34], the best approach to explore the way of these selected miRs impact on NAFLD of aged rats was cell transfection and luciferase reporter gene assays, which can confirm the targeted regulation relationship between miRs and their target genes in lipid metabolism in aged NAFLD rats. However, a single miR can regulate more than 100 target genes; conversely, the expression of a particular gene can be regulated positively or negatively by multiple miRs. So it is required to study and discuss the identified miRs one by one in the future experiments. Among the 10 identified DE-miRs, miR-223-3p demonstrated a higher upregulated expression level in the aged NAFLD group through both high-throughput sequencing methods and qPCR methods, but not highly upregulated in the young NAFLD group, suggesting the possibilities that miR-223-3p may be closely related to the occurrence and development of fatty change or hepatic insulin resistance in the aged. It was interesting to note that miR-223 was involved in the biological processes of cell growth, development and metabolism by targeting glucose transporter (GLUT) 4 [35]. miR-223 had also been demonstrated downregulating insulin-like growth factor-1 and the downstream phosphoinositide 3-kinases/Akt, and mammalian target of rapamycin signaling pathways [36]. These possibilities need to be explored in future experiments so as to explicit the molecular mechanism of miR-223-targeted insulin signaling pathways in hepatic insulin resistance in the aged.

In conclusion, the present study first identified DE-miRs in hepatic tissues of the aged rats with NAFLD, and thus expands the current understanding regarding the molecular etiology of aging-associated NAFLD. Considering that miR is being studied as an important serum biomarker in NAFLD progression, these identified differentially expressed miRs will be verified and explored in subsequent serological studies in human. Furthermore, the functional relevance of these DE-miRs and their potential mechanisms in regulating hepatic insulin resistance were also analyzed using a bioinformatics approach. Further studies are needed to be focused on the impact of these selected DE-miRs and their candidate targets on the aged NAFLD rats in more detail, in order to identify how to control lipid metabolism in NAFLD of the aged and provide the biological basis for prevention and early treatment for NAFLD in the aged population.AbbreviationsmiR

microRNA

nt

nucleotide

NAFLD

non-alcoholic fatty liver disease

DE-miR

differentially expressed microRNA

FBG

fasting blood glucose

FINS

fasting insulin

TPM

transcripts per million

GO

Gene Ontology

KEGG

Kyoto Encyclopedia of Genes and Genomes

Funding

This work was supported by the National Key Research and Development Program of China (grant number 2018YFC2002000); National Natural Science Foundation of China (grant number 81701374); Shanghai Excellent Young Medical Talents Training program (grant number 2018YQ58); Shanghai Municipal Science and Technology Committee Program (grant number YDZX20173100004026); Shanghai Municipal Commission of Health and Family Planning research program and Family Planning research program (grant number 201740216); Shanghai Medical Leadership Training Program (grant number 2019LJ09); and Shanghai Sailing program (grant number 17YF1405200).

Conflict of interest

The authors have no conflicts of interest to declare.

Appendix A

Fig. A.1.

Sequence length distribution diagram of the liver samples of the aged group, which were randomly pooled from 3 aged NAFLD rats (A, B, C) and 3 aged control rats (D, E, F) respectively. The distribution of valid sequences in the two experimental groups had apparent similarities, that is, the mature miRs ranged principally from 21 to 24 nt in length (mostly 22 nt). X-coordinate denotes read lengths after clipping, Y-coordinate denotes number of reads. miRs, microRNAs; NAFLD, non-alcoholic fatty liver disease; nt, nucleotides.

(0.41MB).
Table A.1.

Upregulated miRs.

Gene ID  Fold change  P-value  FDR  Gene ID  Fold change  P-value  FDR 
miR-98-3p  1.230684  0.688396  miR-223-3p  2.267857  7.74×10−12  1.36×10−12 
miR-93-5p  1.261026  0.001653  0.015953  miR-221-3p  1.484292  0.008318  0.071886 
miR-92a-1-5p  1.241321  0.292275  miR-21-5p  1.120631  4.25×10−104  2.74×10−102 
miR-881-3p  2.874598  7.10×10−7  9.34×10−6  miR-21-3p  1.198951  0.118136  0.705161 
miR-871-3p  3.977559  1.05×10−12  2.09×10−11  miR-204-5p  1.159127  0.473252 
miR-743b-3p  1.491166  2.66×10−6  3.42×10−5  miR-203b-3p  1.005348  0.930952 
miR-674-3p  1.062051  0.742528  miR-200b-3p  1.437839  4.73×10−11  8.06×10−10 
miR-671  1.165824  0.480729  miR-200a-3p  1.135863  0.454937 
miR-6329  1.15225  0.594615  miR-19b-3p  1.449333  1.44×10−8  2.14×10−6 
miR-582-3p  1.641567  0.245183  miR-19a-3p  1.443749  0.152972  0.868344 
miR-542-3p  1.293997  0.211163  miR-199a-3p  1.035143  0.518148 
miR-497-5p  1.010333  0.811507  miR-195-5p  1.012771  0.651703 
miR-466c-5p  1.020391  miR-195-3p  1.387836  0.163458  0.91002 
miR-450b-5p  1.099582  0.454764  miR-191b  1.019895  0.837927 
miR-450a-5p  1.213732  0.016527  0.134776  miR-191a-5p  1.167045  3.84×10−65  2.02×10−63 
miR-429  1.086396  0.638434  miR-186-5p  1.436299  1.11×10−54  5.35×10−53 
miR-425-5p  1.214400  0.048836  0.349089  miR-1843b-5p  1.016608 
miR-425-3p  1.167912  0.566186  miR-184  1.492514  0.158657  0.891865 
miR-423-5p  1.467510  1.03×10−9  1.65×10−8  miR-1839-5p  1.215046  0.29665 
miR-423-3p  1.216513  0.005738  0.050341  miR-181d-5p  1.266952  0.509116 
miR-375-3p  1.006099  0.714961  miR-181c-5p  1.006544  0.9037 
miR-365-3p  1.148471  0.058222  0.401315  miR-181b-5p  1.692100  2.72×10−7  3.75×10−6 
miR-363-3p  1.441075  0.200338  miR-181a-5p  1.731038  9.13×10−190  7.55×10−188 
miR-362-5p  1.525023  0.356553  miR-17-5p  1.128717  0.388623 
miR-361-5p  1.061213  0.495463  miR-15b-5p  1.276448  0.080247  0.510583 
miR-361-3p  1.179414  0.393292  miR-155-5p  4.749237  2.89×10−14  6.68×10−13 
miR-3589  1.190087  0.389079  miR-152-5p  1.083824  0.7415 
miR-3586-3p  1.273637  0.035279  0.268768  miR-152-3p  1.134749  0.071344  0.469414 
miR-3585-5p  1.449256  0.307905  miR-151-3p  1.046254  0.034352  0.2652 
miR-3574  1.033192  0.841726  miR-150-5p  1.398956  0.000219  0.002392 
miR-3570  1.485842  0.099049  0.610097  miR-148b-5p  1.105382  0.72632 
miR-3560  1.164105  0.566186  miR-148b-3p  1.107297  0.002992  0.027939 
miR-3557-5p  1.096255  2.10×10−28  7.58×10−27  miR-148a-3p  1.164109  4.62×10−98  2.67×10−96 
miR-351-5p  1.448735  6.75×10−14  1.50×10−12  miR-147  1.715853  0.207499 
miR-342-3p  1.275031  0.113545  0.684817  miR-146b-5p  3.767311  9.13×10−208  1.32×10−205 
miR-340-5p  1.073086  0.403005  miR-146a-5p  1.790339  6.95×10−193  6.71×10−191 
miR-340-3p  1.621818  0.066097  0.445  miR-145-5p  1.108945  0.113188  0.68985 
miR-335  2.072291  3.84×10−8  5.42×10−7  miR-144-5p  1.281066  0.470713 
miR-330-5p  1.326267  0.455788  miR-142-5p  1.504442  9.16×10−36  3.79×10−34 
miR-328a-3p  1.025072  0.791762  miR-142-3p  1.538573  0.003403  0.030784 
miR-322-5p  1.622113  1.99×10−17  5.77×10−16  miR-140-5p  1.171512  0.468567 
miR-322-3p  1.147543  0.421038  miR-140-3p  1.054898  0.376974 
miR-320-3p  1.062367  0.54846  miR-130b-3p  2.252224  0.073922  0.475564 
miR-30d-5p  1.112735  5.47×10−30  2.11×10−28  miR-128-3p  1.273144  0.249252 
miR-30c-5p  1.147895  1.85×10−12  3.45×10−11  miR-127-3p  1.821959  0.096912  0.603356 
miR-30c-2-3p  1.04585  0.804673  miR-125b-5p  1.031797  0.019402  0.156021 
miR-30c-1-3p  1.397398  0.212323  miR-125a-5p  1.159085  6.91×10−9  1.05×10−7 
miR-30b-3p  1.034876  0.879775  miR-1247-5p  1.142019  0.020969  0.166315 
miR-3068-3p  1.041984  0.879775  miR-10b-5p  1.008457  0.52421 
miR-301a-3p  1.350638  0.035473  0.26674  miR-10a-5p  1.113068  8.04×10−242  1.55×10−239 
miR-29c-3p  1.092374  0.186286  miR-107-3p  1.131039  0.046921  0.339591 
miR-28-3p  1.222876  9.27×10−17  2.44×10−15  miR-106b-3p  1.184691  0.726915 
miR-27b-3p  1.108844  7.93×10−26  2.55×10−24  miR-103-3p  1.04185  0.250292 
miR-26b-3p  1.003730  miR-100-5p  1.045216  0.41352 
miR-26a-5p  1.024912  2.45×10−13  5.07×10−12  let-7i-5p  1.353470  2.31×10−17  6.36×10−16 
miR-24-2-5p  1.112468  0.295538  let-7g-5p  1.039784  0.021242  0.166202 
miR-23b-3p  1.021780  0.647588  let-7f-5p  1.127052  1.23×10−26  4.19×10−25 
miR-23a-3p  1.113454  0.049816  0.351748  let-7d-5p  1.028778  0.398171 

Fold change: The ratio of read counts in the NAFLD group to that in control group. FDR: false discovery rate.

After normalization, obtained average values for each miR spot were used for statistics. miR with expression fold change >2 and with FDR <0.05 was considered statistically significant.

Table A.2.

Downregulated miRs.

Gene ID  Fold change  P-value  FDR  Gene ID  Fold change  P-value  FDR 
miR-99b-5p  0.864760  1.10×10−9  1.72×10−8  miR-29a-3p  0.936600  0.0105074  0.0894671 
miR-99a-5p  0.794642  1.59×10−15  3.83×10−14  miR-28-5p  0.935051  0.4503685 
miR-99a-3p  0.844558  0.3235342  miR-27b-5p  0.997097 
miR-98-5p  0.977069  0.952307  miR-27a-3p  0.956311  0.6095062 
miR-96-5p  0.484338  0.003026  0.0278157  miR-26b-5p  0.936908  0.0004992  0.0051614 
miR-92b-3p  0.987446  miR-25-3p  0.965137  0.6368837 
miR-92a-3p  0.915308  0.000431  0.0045373  miR-24-3p  0.861155  0.0106549  0.0894088 
miR-872-5p  0.922944  0.3846609  miR-22-5p  0.612054  0.035499  0.2635117 
miR-872-3p  0.817050  0.4175552  miR-22-3p  0.982265  0.0729203  0.4743918 
miR-802-5p  0.795949  5.24×10−6  6.59×10−5  miR-218a-5p  0.912793 
miR-802-3p  0.70729  0.0000084  0.0001035  miR-215  0.761129  0.5330007 
miR-7a-5p  0.981729  miR-214-3p  0.932059 
miR-7a-1-3p  0.767204  0.4998205  miR-20a-5p  0.955924  0.8372123 
miR-676  0.879956  0.3292199  miR-203b-5p  0.693754  0.005679  0.0505864 
miR-674-5p  0.886986  miR-203a-5p  0.855204  0.4402852 
miR-664-3p  0.904680  0.6516462  miR-203a-3p  0.812334  0.0001746  0.0019443 
miR-652-3p  0.862146  0.5302493  miR-199a-5p  0.992698  0.9413998 
miR-532-5p  0.924892  0.5903448  miR-194-5p  0.857873  3.99×10−16  1.01×10−14 
miR-532-3p  0.886574  0.8388864  miR-194-3p  0.961379  0.9076785 
miR-511-3p  0.761951  0.6901662  miR-193a-3p  0.485741  0.000155  0.001759 
miR-499-5p  0.975272  miR-192-5p  0.760503 
miR-486  0.993033  0.8754077  miR-192-3p  0.863260  0.5167536 
miR-455-5p  0.956251  miR-190a-5p  0.952791 
miR-455-3p  0.888861  0.8747157  miR-188-5p  0.983395 
miR-451-5p  0.561234  0.0004235  0.0045409  miR-185-5p  0.990302 
miR-378b  0.972721  miR-1843a-5p  0.879726  0.4637074 
miR-378a-5p  0.891257  0.5193521  miR-183-5p  0.441220  4.53×10−19  1.38×10−17 
miR-378a-3p  0.790290  0.6179392  miR-182  0.460273  1.60×10−205  1.86×10−203 
miR-374-5p  0.969619  0.9286449  miR-16-5p  0.887731  5.72×10−11  9.46×10−10 
miR-374-3p  0.997573  miR-15a-5p  0.657888  0.0001161  0.0013718 
miR-3596d  0.914204  0.7550294  miR-151-5p  0.954179  0.2989436 
miR-3591  0.694113  0.262858  miR-148a-5p  0.843009  0.0001178  0.0013646 
miR-3590-5p  0.963292  0.6809113  miR-145-3p  0.843984  0.1426235  0.8257903 
miR-3577  0.738388  0.6637398  miR-143-3p  0.720454 
miR-3559-5p  0.902577  0.5356624  miR-141-3p  0.698591  0.0403962  0.2960685 
miR-3559-3p  0.896308  0.7553974  miR-139-5p  0.867019  0.4637074 
miR-3556b  0.795859  0.0014244  0.0139782  miR-135a-5p  0.710011  0.6477152 
miR-3556a  0.968204  0.7082915  miR-126a-5p  0.74114  4.29×10−119  3.10×10−117 
miR-34c-5p  0.833476  0.4512204  miR-126a-3p  0.947902  0.0611461  0.4165131 
miR-34a-5p  0.889775  0.1666213  0.9187973  miR-125b-2-3p  0.897326  0.2084641 
miR-345-5p  0.555800  0.0536557  0.3742969  miR-1249  0.919069  0.8939555 
miR-345-3p  0.830030  0.7202448  miR-1247-3p  0.792811  0.8238637 
miR-339-5p  0.815905  0.2355134  miR-122-5p  0.964713  0.0012034  0.0120137 
miR-339-3p  0.862439  0.3888449  miR-122-3p  0.702651  5.85×10−7  7.88×10−6 
miR-338-3p  0.779046  0.1436181  0.8233154  miR-10a-3p  0.933654 
miR-331-3p  0.514694  0.1216673  0.7188305  miR-106b-5p  0.841216  0.5564896 
miR-33-3p  0.37014  0.2102399  miR-101b-3p  0.749128  1.04×10−42  4.62×10−41 
miR-326-3p  0.912660  miR-101a-3p  0.771402  1.76×10−13  3.77×10−12 
miR-32-5p  0.855168  0.8601272  let-7f-2-3p  0.744605  0.3413418 
miR-31a-5p  0.432146  3.39×10−12  6.14×10−11  let-7f-1-3p  0.869890  0.6780827 
miR-31a-3p  0.454225  0.0127405  0.1053822  let-7e-5p  0.911747  0.5028902 
miR-30e-5p  0.984367  0.782705  let-7d-3p  0.901745  0.2195292 
miR-30e-3p  0.974931  0.822816  let-7c-5p  0.837631  1.63×10−12  3.15×10−11 
miR-30d-3p  0.900329  0.5060937  let-7c-2-3p  0.939931  0.7533534 
miR-30b-5p  0.820991  3.03×10−8  4.39×10−7  let-7b-5p  0.856712  0.002738  0.0259889 
miR-30a-5p  0.954476  1.42×10−5  0.000171  let-7b-3p  0.876047  0.5434269 
miR-30a-3p  0.887117  0.0922375  0.5804944  let-7a-5p  0.926853  0.0008312  0.0084432 
miR-29b-3p  0.837602  0.3431304  let-7a-1-3p  0.946219  0.8142643 

Fold change: The ratio of read counts in NAFLD group to that in control group. FDR: false discovery rate.

After normalization, obtained average values for each miR spot were used for statistics. miR with expression fold change <0.5 and with FDR <0.05 was considered statistically significant.

References
[1]
V. Ambros.
The functions of animal microRNAs.
Nature, 431 (2004), pp. 350-355
[2]
X. Geng, C. Chang, X. Zang, J. Sun, P. Li, J. Guo, et al.
Integrative proteomic and microRNA analysis of the priming phase during rat liver regeneration.
[3]
D.P. Bartel.
MicroRNAs: genomics, biogenesis, mechanism, and function.
[4]
E. Zhao, M.P. Keller, M.E. Rabaglia, A.T. Oler, D.S. Stapleton, K.L. Schueler, et al.
Obesity and genetics regulate microRNAs in islets, liver, and adipose of diabetic mice.
Mamm Genome, 20 (2009), pp. 476-485
[5]
T. Liang, C. Liu, Z. Ye.
Deep sequencing of small RNA repertoires in mice reveals metabolic disorders-associated hepatic miRNAs.
[6]
V. Rottiers, A.M. Naar.
MicroRNAs in metabolism and metabolic disorders.
Nat Rev Mol Cell Biol, 13 (2012), pp. 239-250
[7]
I. Martinez, L.L. Almstead, D. DiMaio.
MicroRNAs and senescence.
Aging (Albany, NY), 3 (2011), pp. 77-78
[8]
Y.J. Kim, S.H. Hwang, S.Y. Lee, K.K. Shin, H.H. Cho, Y.C. Bae, et al.
miR-486-5p induces replicative senescence of human adipose tissue-derived mesenchymal stem cells and its expression is controlled by high glucose.
Stem Cells Dev, 21 (2012), pp. 1749-1760
[9]
D. Xu, F. Takeshita, Y. Hino, S. Fukunaga, Y. Kudo, A. Tamaki, et al.
miR-22 represses cancer progression by inducing cellular senescence.
J Cell Biol, 193 (2011), pp. 409-424
[10]
J.G. Fan, Z.J. Xu, G.L. Wang.
Effect of lactulose on establishment of a rat non-alcoholic steatohepatitis model.
World J Gastroenterol, 11 (2005), pp. 5053-5056
[11]
European Association for the Study of the L, European Association for the Study of D, European Association for the Study of O.
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease.
J Hepatol, 64 (2016), pp. 1388-1402
[12]
D.G. Tiniakos.
Nonalcoholic fatty liver disease/nonalcoholic steatohepatitis: histological diagnostic criteria and scoring systems.
Eur J Gastroenterol Hepatol, 22 (2010), pp. 643-650
[13]
G. Chen, C. Zhang, F. Jiang, Y. Wang, Z. Xu, C. Wang.
Bioinformatics analysis of hemocyte miRNAs of scallop Chlamys farreri against acute viral necrobiotic virus (AVNV).
Fish Shellfish Immunol, 37 (2014), pp. 75-86
[14]
H. Yu, L. Cong, Z. Zhu, C. Wang, J. Zou, C. Tao, et al.
Identification of differentially expressed microRNA in the stems and leaves during sugar accumulation in sweet sorghum.
[15]
M.R. Dalman, A. Deeter, G. Nimishakavi, Z.H. Duan.
Fold change and p-value cutoffs significantly alter microarray interpretations.
BMC Bioinform, 13 (2012), pp. S11
[16]
M. Ashburner, C.A. Ball, J.A. Blake, D. Botstein, H. Butler, J.M. Cherry, et al.
Gene ontology: tool for the unification of biology. The Gene Ontology Consortium.
Nat Genet, 25 (2000), pp. 25-29
[17]
D. Betel, M. Wilson, A. Gabow, D.S. Marks, C. Sander.
The microRNA.org resource: targets and expression.
Nucleic Acids Res, 36 (2008), pp. D149-D153
[18]
M. Kanehisa, S. Goto.
KEGG: Kyoto Encyclopedia of Genes and Genomes.
Nucleic Acids Res, 28 (2000), pp. 27-30
[19]
L. Ye, X. Su, Z. Wu, X. Zheng, J. Wang, C. Zi, et al.
Analysis of differential miRNA expression in the duodenum of Escherichia coli F18-sensitive and -resistant weaned piglets.
[20]
H. Yatsuya, T. Nihashi, Y. Li, Y. Hotta, K. Matsushita, T. Muramatsu, et al.
Independent association of liver fat accumulation with insulin resistance.
Obes Res Clin Pract, 8 (2014), pp. e350-e355
[21]
O. Kucera, Z. Cervinkova.
Experimental models of non-alcoholic fatty liver disease in rats.
World J Gastroenterol, 20 (2014), pp. 8364-8376
[22]
A. Davalos, L. Goedeke, P. Smibert, C.M. Ramirez, N.P. Warrier, U. Andreo, et al.
miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling.
Proc Natl Acad Sci U S A, 108 (2011), pp. 9232-9237
[23]
H.S. Ryu, S.Y. Park, D. Ma, J. Zhang, W. Lee.
The induction of microRNA targeting IRS-1 is involved in the development of insulin resistance under conditions of mitochondrial dysfunction in hepatocytes.
[24]
C. Brons, L.G. Grunnet.
Mechanisms in Endocrinology: skeletal muscle lipotoxicity in insulin resistance and type 2 diabetes: a causal mechanism or an innocent bystander?.
Eur J Endocrinol, 176 (2017), pp. R67-R78
[25]
G. Li, X. Liu, H. Zhu, L. Huang, Y. Liu, C. Ma, et al.
Insulin resistance in insulin-resistant and diabetic hamsters (Mesocricetus auratus) is associated with abnormal hepatic expression of genes involved in lipid and glucose metabolism.
Comp Med, 59 (2009), pp. 449-458
[26]
O. Cheung, P. Puri, C. Eicken, M.J. Contos, F. Mirshahi, J.W. Maher, et al.
Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression.
Hepatology, 48 (2008), pp. 1810-1820
[27]
N. Liu, M. Landreh, K. Cao, M. Abe, G.J. Hendriks, J.R. Kennerdell, et al.
The microRNA miR-34 modulates ageing and neurodegeneration in Drosophila.
Nature, 482 (2012), pp. 519-523
[28]
T. Seeger, R.A. Boon.
MicroRNAs in cardiovascular ageing.
J Physiol, 594 (2016), pp. 2085-2094
[29]
A. Alisi, L. Da Sacco, G. Bruscalupi, F. Piemonte, N. Panera, R. De Vito, et al.
Mirnome analysis reveals novel molecular determinants in the pathogenesis of diet-induced nonalcoholic fatty liver disease.
Lab Investig, 91 (2011), pp. 283-293
[30]
I.P. Pogribny, A. Starlard-Davenport, V.P. Tryndyak, T. Han, S.A. Ross, I. Rusyn, et al.
Difference in expression of hepatic microRNAs miR-29c, miR-34a, miR-155, and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in mice.
Lab Investig, 90 (2010), pp. 1437-1446
[31]
X.W. Wang, N.H. Heegaard, H. Orum.
MicroRNAs in liver disease.
Gastroenterology, 142 (2012), pp. 1431-1443
[32]
R.C. Friedman, K.K. Farh, C.B. Burge, D.P. Bartel.
Most mammalian mRNAs are conserved targets of microRNAs.
Genome Res, 19 (2009), pp. 92-105
[33]
M. Jiwaji, R. Daly, K. Pansare, P. McLean, J. Yang, W. Kolch, et al.
The Renilla luciferase gene as a reference gene for normalization of gene expression in transiently transfected cells.
BMC Mol Biol, 11 (2010), pp. 103
[34]
L.J. Miraglia, F.J. King, R. Damoiseaux.
Seeing the light: luminescent reporter gene assays.
Comb Chem High Throughput Screen, 14 (2011), pp. 648-657
[35]
H. Lu, R.J. Buchan, S.A. Cook.
MicroRNA-223 regulates Glut4 expression and cardiomyocyte glucose metabolism.
Cardiovasc Res, 86 (2010), pp. 410-420
[36]
C.Y. Jia, H.H. Li, X.C. Zhu, Y.W. Dong, D. Fu, Q.L. Zhao, et al.
MiR-223 suppresses cell proliferation by targeting IGF-1R.
Copyright © 2019. Fundación Clínica Médica Sur, A.C.
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos